已收盘 03-20 16:00:00 美东时间
0.000
0.00%
Alterity Therapeutics announced a successful capital raise of A$20 million to fund the development of its lead drug ATH434 for treating neurodegenerative diseases like MSA. CEO David Stamler highlighted positive Phase 2 trial results and the company’s strategic focus on advancing regulatory and clinical activities. Proceeds will strengthen Alterity’s balance sheet, support ongoing research, and facilitate potential partnerships.
09-08 11:35
Alterity Therapeutics, a biotech company focused on neurodegenerative disease treatments, announced that CEO David Stamler will present a corporate update at the Biotech Showcase on September 3, 2025, in Australia, and September 2, 2025, in the U.S. The presentation will highlight the company's lead asset, ATH434, and its drug discovery platform. Zoom webcast registration details and contact information for investors and media are provided. The a...
09-02 11:25
Orasure stock price has dropped 11% in 4 weeks, 32% in 12 monthsZwanziger offered $3.50-$4 a share, price now under $3/shareOrasure Tech makes COVID-19 rapid-antigen testsLetter says $40 million share repurchase program
08-26 00:03
海信正式推出海信TriChroma激光电视L9Q。L9Q具有5000 ANSI流明的亮度和5000:1对比度,通过三重激光技术实现精准光线控制与鲜活色彩还原。...
08-15 17:11
上海,2025年7月9日,2025年中国国际铝工业展览会现场——今日(7月9日),备受瞩目的2025年中国国际铝工业展览会在上海新国际博览中心盛大开幕。特浦...
07-09 16:04
ALR Technologies ( ($ALRTF) ) just unveiled an update. ALR Technologies SG Ltd....
06-27 01:57
转自:前瞻产业研究院 行业主要上市公司:基蛋生物;万泰生物;安图生物;热景生物;安旭生物;诺唯赞;圣湘生物;东方生物;之江生物;硕世生物;奥泰生物;博拓生物;科...
2024-03-19 14:31
NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ:NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and
2024-02-22 05:46
IVD业务火了,“地位”也随之上升。 相比疫情爆发之前的2019半年报,可以明显看出IVD业务在各个公司内部占比都在攀升,其中上涨最多的、新冠诊断赛道的最大受益...
2022-08-04 10:21